PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

BMY-2023-Q1-Results-Presentation-Appendix - Bristol Myers Squibb | Presentation Nation

HomepageBristol Myers SquibbBMY-2023-Q1-Results-Presentation-Appendix

BMY-2023-Q1-Results-Presentation-Appendix

Bristol Myers Squibb

Browse presentations, reports, and documents from Bristol Myers Squibb.

Tags

2023

Filter options

All (143)●
report (20)○
conference (3)○
infographic (15)○
whitepaper (2)○
investor_presentation (1)○
presentation (63)○
annual_report (2)○
brochure (37)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

BMY-2023-Q1-Results-Presentation-Appendix by Bristol Myers Squibb.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Bristol Myers Squibb

201217_Updated_COVID-9%20Infographic%20NOUK2001369-01

infographic

2019-BMY-CELG-JPM-Investor-Presentation

presentation

Similar presentations from other companies

GPA-2024-Market-Report-Final

presentation

Golf Property Analysts

Mapi-Pharma-Corporate-Presentation-2019

presentation

Mapi Pharma

Kite Realty Group Trust__2023__45_95045

2022-bms-annual-report

report

2022-Q2-Quarterly-Earnings-Infographic

infographic

2022-Q3-Quarterly-Earnings-Infographic

infographic

2022-Q4-Quarterly-Earnings-Infographic

infographic

presentation

Kite Realty Group

5bc2c1d7-aa4d-4833-ad32-4e7b35fa1bd4

presentation

EuroGroup Laminations

Evotec_August_2020_514_59514

presentation

Evotec SE

CASI Pharmaceuticals_February_2019_567_38567

presentation

CASI Pharmaceuticals